Atrial fibrillation (AFib) is the most common cardiac arrhythmia worldwide and a major contributor to heart failure (HF), ...

In 1980, Ludwig and colleagues described the histologic features of a newly identified chronic liver condition referred to as nonalcoholic steatohepatitis (NASH) and noted that the majority of the ...

A large population-based study has found that older adults with atrial fibrillation who also have metabolic dysfunction-associated steatotic liver disease face a significantly higher risk of ...

Intestinal failure–associated liver disease (IFALD) is a major concern in the management of pediatric intestinal failure, representing a leading cause of ...

The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows improvements for patients with progressive liver disease, finds a clinical ...

What Is Metabolic Dysfunction-Associated Steatohepatitis? Metabolic dysfunction-associated steatohepatitis, or MASH, is a form of liver disease. MASH occurs when fat accumulates in liver cells. Plenty ...

When most people think about liver disease, they think about alcohol or hepatitis. What many don’t realize is that the most ...

A new 2026 study reveals how chronic stress depletes NAD⁺, impairing immunity and accelerating liver cancer—while linking the ...

Ipilimumab-nivolumab also linked with better survival but more toxicity in small study ...